By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Antipsychotic > Risperidone

Risperidone

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|599 words

Risperidone: Antipsychotic Medication Profile

What is Risperidone?

Risperidone is an atypical antipsychotic medication belonging to the benzisoxazole class of drugs. It is primarily prescribed to treat schizophrenia, bipolar disorder, and certain behavioral problems in children and adolescents with autism. This medication helps restore the balance of neurotransmitters in the brain to improve mood, thinking, and behavior.

Uses

Risperidone has several FDA-approved therapeutic uses:

  • Schizophrenia: Helps manage symptoms such as hallucinations, delusions, and disorganized thinking in adults and adolescents aged 13-17
  • Bipolar I disorder: Used as monotherapy or combined with lithium or valproate to treat acute manic or mixed episodes
  • Autism spectrum disorder: Treats irritability, aggression, and self-injurious behavior in children and adolescents aged 5-16
  • Maintenance therapy: Long-term treatment to prevent relapse in patients with bipolar disorder or schizophrenia
  • Behavioral disorders: Sometimes prescribed off-label for severe behavioral problems in children with developmental disabilities

How it works

Risperidone works by blocking dopamine and serotonin receptors in the brain, particularly D2 dopamine receptors and 5-HT2A serotonin receptors. By modulating these neurotransmitter pathways, it helps reduce psychotic symptoms while having less impact on movement-related side effects compared to older antipsychotic medications. This dual receptor action makes it effective for treating both positive symptoms (hallucinations, delusions) and negative symptoms (social withdrawal, lack of motivation) of psychiatric disorders.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Weight gain and increased appetite
  • Drowsiness and fatigue
  • Dizziness and orthostatic hypotension
  • Extrapyramidal symptoms (tremor, muscle stiffness)
  • Nausea and constipation
  • Increased prolactin levels
  • Anxiety and agitation
  • Dry mouth

Serious side effects requiring immediate medical attention:

  • Neuroleptic malignant syndrome (fever, muscle rigidity, altered mental status)
  • Tardive dyskinesia (involuntary muscle movements)
  • Severe allergic reactions
  • Significant changes in blood sugar or cholesterol levels
  • Seizures or loss of consciousness

Warnings and precautions

  • Black box warning: Increased risk of death in elderly patients with dementia-related psychosis; not approved for this use
  • Pregnancy category C: Should only be used during pregnancy if potential benefits outweigh risks; may cause withdrawal symptoms in newborns
  • Metabolic monitoring: Regular monitoring of weight, blood glucose, and lipid levels is recommended due to risk of metabolic syndrome
  • Cardiovascular risks: Use with caution in patients with heart disease, as it may cause QT prolongation and orthostatic hypotension
  • Kidney/liver impairment: Dose adjustments may be necessary in patients with hepatic or renal dysfunction

Interactions

  • Carbamazepine: Significantly reduces risperidone levels by increasing its metabolism; dose adjustments needed
  • Fluoxetine and paroxetine: These antidepressants can increase risperidone levels by inhibiting its breakdown
  • CNS depressants (alcohol, benzodiazepines): Enhanced sedation and respiratory depression risk
  • Levodopa and dopamine agonists: Risperidone may antagonize their therapeutic effects
  • Antiarrhythmic drugs: Increased risk of QT prolongation and cardiac arrhythmias
  • Blood pressure medications: May enhance hypotensive effects
  • Clozapine: May decrease clozapine clearance, requiring dose monitoring
  • Galantamine and donepezil: Potential for enhanced cholinergic effects

Check interactions with the GMJ Interaction Checker

Dosage

Dosage varies significantly based on the condition being treated and individual patient factors. For schizophrenia in adults, the typical starting dose is 1-2 mg twice daily, with gradual increases to an effective dose range of 4-8 mg daily. For bipolar disorder, doses typically range from 2-6 mg daily. In autism-related irritability, children usually start at 0.25-0.5 mg daily with careful dose titration. Elderly patients and those with kidney or liver problems generally require lower starting doses. All dosing decisions should be made by a qualified healthcare provider who can assess individual patient needs and monitor response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Risperidone." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/risperidone/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
How Coffee and Tea Reduce Iron Absorption: A Mechanism Explained

Polyphenols in coffee and tea bind non-heme iron in the gut, reducing…

Eggs and Alzheimer’s risk: New evidence from a 15-year study challenges decades of dietary caution

A 15-year study of 39,498 older adults found that eating eggs five…

Sleep loss triggers simultaneous damage across seven body systems, new evidence shows

Controlled studies show that restricting sleep to 4–6 hours per night for…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Lurasidone

By
Prof. Giorgi Pkhakadze
02/06/2026

Olanzapine

By
Prof. Giorgi Pkhakadze
02/06/2026

Ziprasidone

By
Prof. Giorgi Pkhakadze
02/06/2026

Haloperidol

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up